N6AMT2 inhibitors belong to a specific chemical class that exerts its effects by targeting and modulating the activity of the enzyme N6-adenine methyltransferase 2 (N6AMT2). This enzyme plays a crucial role in the process of methylation, where it adds a methyl group to the N6 position of adenine in specific nucleic acid sequences. By inhibiting N6AMT2, these compounds interfere with the methylation process and disrupt the normal pattern of epigenetic modifications on nucleic acids.
Epigenetic modifications are essential for regulating gene expression and controlling various cellular processes. N6AMT2 inhibitors can alter the epigenetic landscape, potentially leading to changes in gene expression and cellular function. These compounds may have a wide range of applications in research and development, enabling scientists to investigate the role of specific genes and epigenetic mechanisms in various biological processes. Overall, N6AMT2 inhibitors represent a valuable tool for researchers to explore the complex relationship between epigenetic modifications and cellular functions, contributing to a deeper understanding of molecular biology and potentially uncovering novel avenues for scientific exploration.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
STF 31 | 724741-75-7 | sc-364692 | 10 mg | $187.00 | 3 | |
Another inhibitor of N6AMT2, potentially affecting NAD+ metabolism and cell viability in certain cancer cells. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
An investigational compound that showed inhibition of N6AMT2 in research studies, with implications for cancer therapy. | ||||||